Vycor Medical (VYCO) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.80% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.94% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -35.05% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.28% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -4.98% |
| 10 | Vycor Medical | - | - | 375,153.00 | 13.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.24% |
| Dec 31, 2025 | 77.28% |
| Sep 30, 2025 | 32.00% |
| Jun 30, 2025 | 36.56% |
| Mar 31, 2025 | 47.37% |
| Dec 31, 2024 | 26.49% |
| Sep 30, 2024 | 36.53% |
| Jun 30, 2024 | -25.50% |
| Mar 31, 2024 | 70.19% |
| Dec 31, 2023 | 44.15% |
| Sep 30, 2023 | 58.45% |
| Jun 30, 2023 | 31.52% |
| Mar 31, 2023 | 28.26% |
| Dec 31, 2022 | -95.75% |
| Sep 30, 2022 | 35.14% |
| Jun 30, 2022 | 33.08% |
| Mar 31, 2022 | 41.97% |
| Dec 31, 2021 | 40.33% |
| Sep 30, 2021 | 21.28% |
| Jun 30, 2021 | 26.09% |
| Dec 31, 2020 | 96.05% |
| Jun 30, 2020 | 95.80% |
| Mar 31, 2020 | 62.76% |
| Dec 31, 2019 | 23.97% |
| Sep 30, 2019 | 22.75% |
| Jun 30, 2019 | 52.64% |
| Jun 30, 2017 | -2,466.54% |
| Mar 31, 2017 | -146.99% |
| Dec 31, 2016 | -65.62% |
| Sep 30, 2016 | -68.20% |
| Jun 30, 2016 | -132.58% |
| Sep 30, 2014 | 2.45% |
| Jun 30, 2014 | 22.85% |
| Mar 31, 2014 | 8.35% |
| Dec 31, 2013 | 38.27% |
| Sep 30, 2013 | 27.42% |
| Jun 30, 2013 | 18.73% |